Published in Cardiovascular Device Liability Week, February 4th, 2007
Study 1: Scientists discuss in "Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulation" new findings in cardiology. According to a study from the United States, "The Na+-Ca2+ exchanger (NCX1) is up-regulated in hypertrophy and is often found up-regulated in end-stage heart failure. Studies have shown that the change in its expression contributes to contractile dysfunction."
"We have previously shown that the 1831-bp Ncx1 H1 (1831Ncx1) promoter directs cardiac-specific expression of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.